Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
11/2005
11/10/2005US20050250707 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
11/10/2005US20050249976 Material for organic electroluminescence devices and organic electroluminescence device using the material
11/10/2005US20050249669 Quadruplex stabilizer
11/10/2005DE102004019492A1 Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel Selected CGRP antagonists, processes for their preparation and their use as medicaments
11/10/2005CA2564589A1 Tri-substituted ureas as cytokine inhibitors
11/10/2005CA2564587A1 Tri-substituted ureas as cytokine inhibitors
11/10/2005CA2564303A1 Novel pyrrole derivatives with angiotensin ii antagonist activity
11/10/2005CA2564175A1 Chemical compounds
11/10/2005CA2563963A1 3-heterocyclyl-4-phenyl-triazole derivatives as inhibitors of the vasopressin v1a receptor
11/10/2005CA2563222A1 Novel imidazoles
11/10/2005CA2563063A1 Purification of progesterone receptor modulators
11/09/2005EP1593677A2 Benzylidene-thiazolidinediones and analogues and their use in the treatment of diabetes
11/09/2005EP1592695A1 Pyrimidines, methods for the production thereof, and use thereof
11/09/2005EP1592686A1 Gyrase inhibitors and uses thereof
11/09/2005EP1592684A1 Malonamide derivatives as gamma-secretase inhibitors
11/09/2005EP1592683A2 Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands
11/09/2005EP1592425A2 New arylpiperazinyl compounds
11/09/2005EP1592389A2 Piperazine-2-carboxamide derivatives
11/09/2005EP1501787B1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substiituent on the methyl useful as bradykinin antagonists
11/09/2005EP1089973B1 Amidino and guanidino azetidinone tryptase inhibitors
11/09/2005EP0943008B1 Metal mediated serine protease inhibitors
11/09/2005CN1694875A 5-aryltetrazole compounds and uses thereof
11/09/2005CN1694873A Vanilloid receptor ligands and their use in treatments
11/09/2005CN1694704A Use of (1H-benzimidazole-2-yl)-(piperazineyl)- ketaderavitive and correlative compound used as histamine H4 receptor antagonist for the treatment of allergy and asthma
11/09/2005CN1226292C Diazesuberane derivant or its salt
11/08/2005US6962995 Phenanthroline derivatives
11/08/2005US6962936 Treating diseases such as cancer, inflammatory disorders, restenosis,
11/08/2005US6962923 Pyrazole compositions
11/08/2005US6962922 Alkynylated quinazoline compounds
11/08/2005US6962916 For therapy of retrovirus infection
11/08/2005CA2195677C Endothelin antagonists
11/08/2005CA2157288C Methods and compositions for inhibition of angiogenesis
11/08/2005CA2155104C Heterocyclic-substituted alkyl amide acat inhibitors
11/03/2005WO2005103040A1 Cc-1065 analogues for use against cancers
11/03/2005WO2005103037A2 Selected cgrp antagonists, methods for the production thereof, and use thereof as medicaments
11/03/2005WO2005103036A1 Pyrimidin-4-yl-1h-indazol-5yl-amines as chk1 kinases inhibitors
11/03/2005WO2005103035A1 Modified fischer indole synthesis of eletriptan
11/03/2005WO2005103033A1 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof
11/03/2005WO2005103022A1 Substituted thiazole and pyrimidine derivatives as melanocortin receptor modulators
11/03/2005WO2005102998A1 Novel androgens
11/03/2005WO2005102964A2 Porous carbon structures and methods
11/03/2005WO2005102340A1 Piperazine melanocortin-specific compounds
11/03/2005WO2005082079A3 Tetracyclic lactam derivatives and uses thereof
11/03/2005WO2005054212A3 Electroluminescent device
11/03/2005WO2005003103A3 2, 4, 6-tri-substituted 6-membered heterocycles and their use in the treatment of neurodegenerative diseases
11/03/2005WO2002004440A9 Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives
11/03/2005US20050245596 Derivatives of 1-(oxoaminoacetyl) pentylcarbamate as cathepsin k inhibitors for the treatment of bone loss
11/03/2005US20050245592 2-Iminopyrrolidine derivatives
11/03/2005US20050245591 Improved preparation of alpha -polymorphic eletriptan hydrobromide, by salt formation in a solution of 2-butanone and water, distillation, dehydration, desolventizing; purity, white color crystals
11/03/2005US20050245586 2,5-Dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase mmp12
11/03/2005US20050245580 Novel substituted dihydro 3-halo-1H-pyrazole-T-carboxylates, their preparation and use
11/03/2005US20050245555 Tri-substituted ureas as cytokine inhibitors
11/03/2005US20050245551 Amide derivatives
11/03/2005US20050245538 Dipeptidyl peptidase inhibitor; antidiabetic agents; obesity; viricides; anticancer agents; oral diseases; autoimmune disease
11/03/2005US20050245527 Nitrogen containing heterocyclic compounds and medicines containing the same
11/03/2005US20050245526 Beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositions
11/03/2005US20050245525 Compounds useful for inhibiting CHK1
11/03/2005US20050245521 3-[-2-(Piperazin-1-yl)benzyl]pyrrolidin-2-one derivatives; antidepressants, anxiolytic agents; obsessive compulsive disorder, psychological disorders, phobias; 5-HT1 agonist or antagonists; side effect reduction, in particular cardiac QTc prolongation; hydrogenation
11/03/2005US20050245515 Indolyl derivatives as liver-X-receptor (LXR) modulators
11/03/2005US20050245511 Novel compounds that inhibit tryptase activity
11/03/2005US20050245499 Heterocyclic protein kinase inhibitors and uses thereof
11/03/2005US20050245399 Pyrazole derivatives as herbicidal compositions containing them
11/03/2005US20050244976 Methods for detecting anionic and non-anionic compositions using carbocyanine dyes
11/03/2005CA2565219A1 Selected cgrp antagonists, methods for the production thereof, and use thereof as medicaments
11/03/2005CA2562571A1 Novel androgens
11/03/2005CA2562417A1 Piperidine derivatives as modulators of chemokine receptor ccr5
11/03/2005CA2562100A1 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof
11/02/2005EP1591444A1 CCR5 antagonists useful for treating aids
11/02/2005EP1591443A1 Pyrazole derivative
11/02/2005EP1590344A2 Anti-cancer medicaments
11/02/2005EP1590343A1 Synthesis of 2-butyl-3-(2 -(1-trityl-1h-tetrazol-5-yl)biphen yl-4-yl)-1,3-diazaspirol 4,4 -non-ene-4-one
11/02/2005EP1590340A1 Inhibitors of histone deacetylase
11/02/2005EP1590336A2 Substituted pyrazoles, compositions containing such compounds and methods of use
11/02/2005EP1590334A1 2,4-diaminopyrimidine derivatives useful as inhibitors of pkc-theta
11/02/2005EP1590329A1 N-aryl heteroaromatic products, compositions containing same and use thereof
11/02/2005EP1590326A2 Substituted alkyl amido piperidines
11/02/2005EP1590325A1 3,6-disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists
11/02/2005EP1589966A2 Preparation of new pharmaceutically suitable salt of losartan and forms thereof with new purification and isolation methods
11/02/2005EP1501515B1 Triaryl-oxy-aryloxy-pyrimidine-2,4,6-trione metalloproteinase inhibitors
11/02/2005EP1373254B1 Process for the preparation of the anti-migraine drug eletriptan
11/02/2005EP1311501B1 Antithrombotic agents
11/02/2005EP1246807B1 Novel hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines
11/02/2005EP1177190B1 USE OF SELECTIVE ANTAGONISTS OF THE ALPHA 1b-ADRENERGIC RECEPTOR FOR IMPROVEMENT OF SEXUAL DYSFUNCTION
11/02/2005EP1102767B1 Substituted pyrazole derivatives
11/02/2005EP1045833B1 2,3-substituted indole compounds as cox-2 inhibitors
11/02/2005EP0929520B1 Indolinone combinatorial libraries and related products and methods for the treatment of disease
11/02/2005CN1692109A Novel compounds as NS3-serine protease inhibitors of hepatitis c virus
11/02/2005CN1225467C Diazocines compound and method for preparing it using slime bacteria fermentation and extraction method
11/02/2005CN1225465C Novel compounds
11/01/2005US6960667 Such as 1,1'-(1,2-ethanediyl)bis(3,4-diphenyl)-1H-pyrrole-2,5-dione; improved photostability
11/01/2005US6960612 Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith
11/01/2005US6960609 Analgesics; central nervous system disorders; gastrointestinal disorder; therapy for drug abruse ; antiinflammatory agents
11/01/2005US6960601 Imidazole derivatives; appetite suppressants
11/01/2005US6960592 erectile dysfunction; halosulfonation of 2-ethoxy benzoic acid, sulfonamidation, haloacylation, deacylation and amidation, cyclization; phosphodiesterase inhibitor; side-effect reduction; long lasting
11/01/2005US6960591 Propane-1,3-dione derivative
11/01/2005US6960589 Administering to a mammal suffering from sexual disorder a benzimidazole derivative containing piperazine or piperidine ring
11/01/2005US6960586 Having a steroid C17,20-lyase inhibitory activity; useful as prophylactic or therapeutic agent for prostate and breast cancers
11/01/2005US6960582 Such as (3S)-N-(2-(2-(2,4-dichlorophenyl)ethyl)-1-oxo-2,3-dihydro-1H-isoindol-5-yl) -3-methyl-N'-((1S,2S,3S,5R)-2,6,6-trimethylbicyclo(3.1.1)hept-3 -yl)piperazine-1-carboximidamide for treatment of obesity or type II diabetes
11/01/2005US6960578 Glutamate receptor antagonists
11/01/2005US6960575 Thiazine derivatives
1 ... 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 ... 626